Mark W. Frohlich, See Remarks at Juno Therapeutics, Inc. (JUNO), sold 20,000 shares at $35.25 ($705K) on 2016-02-29, disclosed to the SEC on 2016-03-02.
Open-market sale of $705k JUNO by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.25 | 19,700 | $694K | 98.4% |
| 2 | $36.50 | 300 | $11K | 1.6% |
| Total | $35.27 avg | 20,000 | $705K | 100% |
| Filing → |
| DNDN | SELL | 2011-11-16 | $54K | — | Filing → |
| DNDN | SELL | 2011-10-25 | $33K | — | Filing → |
| DNDN | SELL | 2011-07-25 | $126K | — | Filing → |